RxDoctor Payments Data

Margaret Kelley

Family · Anderson, SCNPI 1396159133

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.3% of the total across 570 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 8.5% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,482in general payments, 2019–2025

Across 570 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$979
  • AstraZeneca$836
  • Daiichi Sankyo Inc.$700
  • Incyte Corporation$560
  • Seagen Inc.$505
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$11,51592%
  • Education$9668%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis49$1,066
Johnson & Johnson37$979
AstraZeneca(2 entities)38$836
Daiichi Sankyo Inc.30$700
Incyte Corporation25$560
Seagen Inc.18$505
Bristol Myers Squibb25$492
Bayer18$473
Merck22$462
Eisai Inc.22$455
Gilead(2 entities)14$374
Sanofi11$360
Amgen14$278
Astellas Pharma US Inc10$249
Pfizer13$240
E.r. Squibb & Sons, L.L.C.13$232
Ipsen Biopharmaceuticals, Inc9$222
Lilly USA, LLC12$208
Kyowa Kirin, Inc.7$190
Genentech USA, Inc.12$183
AbbVie8$175
Acrotech Biopharma Inc.8$167
Takeda Pharmaceuticals U.S.A., Inc.7$155
Beigene USA, Inc.10$150
Jazz Pharmaceuticals Inc.8$148
EMD Serono, Inc.8$140
Exelixis Inc.7$132
Astellas Pharma Global Development2$127
Pharmacosmos Therapeutics Inc.7$126
Regeneron Healthcare Solutions, Inc.5$123
Boehringer Ingelheim6$123
Taiho Oncology, Inc.6$120
Sumitomo Pharma America, Inc.4$106
G1 Therapeutics, Inc.6$101
Alnylam Pharmaceuticals Inc.4$85
Blueprint Medicines Corporation4$81
Adaptive Biotechnologies Corporation4$80
Stemline Therapeutics Inc.3$76
AVEO Pharmaceuticals, Inc.4$76
GSK5$75
Mirati Therapeutics, Inc.3$69
Rigel Pharmaceuticals, Inc.4$68
Springworks Therapeutics, Inc.3$62
Coherus Oncology, Inc.4$62
Agios Pharmaceuticals, Inc.3$60
Tersera Therapeutics LLC3$59
Dendreon Pharmaceuticals LLC1$49
Novocure Inc.2$44
Myovant Sciences Inc.2$42
Genmab U.S., Inc.2$41
Array Biopharma Inc3$40
Sobi, Inc2$37
ADC Therapeutics America, Inc.2$34
Pharmacyclics LLC, An Abbvie Company2$32
Puma Biotechnology, Inc.2$32
Accord Healthcare, Inc.1$28
Deciphera Pharmaceuticals Inc.1$27
Pharmaessentia USA Corporation2$27
Caris MPI, Inc.1$24
Organon1$22

How this compares

$12,482 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$10,418
Dexamethasone54$804
Albuterol Sulfate HfaAlbuterol Sulfate22$639
Ondansetron Hcl54$557
Prochlorperazine Maleate28$374
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$341
Olanzapine24$298
Hydroxyurea12$266
Lidocaine-PrilocaineLidocaine/Prilocaine17$220
Fluconazole14$187
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine20$134
Acyclovir14$107
Anastrozole11$96
Levothyroxine Sodium31$95
Pantoprazole Sodium15$90

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$240$10,41814 claims
Lilly USA, LLCOlanzapine$208$29824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.

Other family in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →